New Study Shows Straticyte™ Demonstrates More Quantitative and Objective Assessment Over Dysplasia Grading

A new study published by CIMTEC client Proteocyte provides further data showing Straticyte offers better predictive insight over histopathological dysplasia grading for oral potentially malignant lesion assessment. The study “Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment” was just published online in Oral Oncology.